Background Recent studies indicate an increased frequency of mutations in the gene
encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among …

Background Mutations in LRRK2, the gene that encodes leucine-rich repeat kinase 2, are a
cause of Parkinson's disease (PD). The International LRRK2 Consortium was established to …

Parkinson's disease is a common disorder that leads to motor and cognitive disability. We
performed a genome-wide association study of 2,000 individuals with Parkinson's disease (…

Background There is mounting evidence for a connection between the gut and Parkinson's
disease (PD). Dysbiosis of gut microbiota could explain several features of PD. Objective The …

Biomarkers are urgently needed for the diagnosis and monitoring of disease progression in
Parkinson’s disease. Both DJ-1 and α-synuclein, two proteins critically involved in Parkinson’…

More than 800 published genetic association studies have implicated dozens of potential
risk loci in Parkinson's disease (PD). To facilitate the interpretation of these findings, we have …

Extracellular α-synuclein is important in the pathogenesis of Parkinson’s disease (PD) and
also as a potential biomarker when tested in the cerebrospinal fluid (CSF). The performance …

Objective: There is a clear need to develop biomarkers for Parkinson disease (PD) diagnosis,
differential diagnosis of Parkinsonian disorders, and monitoring disease progression. We …

Background Great heterogeneity exists in survival and the interval between onset of motor
symptoms and dementia symptoms across synucleinopathies. We aimed to identify genetic …

Parkinson disease (PD) is the second most common neurodegenerative disorder. In most
instances, PD is thought to result from a complex interaction between multiple genetic and …